FDA permits transient import of unapproved Chinese most cancers drug to ease US scarcity
Worker labors on a manufacturing line on the manufacturing facility of Qilu Pharmaceutical in Haikou, Hainan province of China, February 11, 2022. Su Bikun | VCG | Getty Images The US Food and Drug Administration has approved the transient importation of an unapproved chemotherapy drug from China so that you can ease an acute shortage … Read more